169 related articles for article (PubMed ID: 16877827)
1. Factor V Leiden is not commonly associated with idiopathic portal vein thrombosis in southern India.
Koshy A; Jeyakumari M
Indian J Gastroenterol; 2006; 25(3):140-2. PubMed ID: 16877827
[TBL] [Abstract][Full Text] [Related]
2. Portal, splenic and mesenteric vein thrombosis in a patient with factor V Leiden mutation and antithrombin III deficiency.
Otrock ZK; Soweid AM; Salem ZM; Jamali FR
Ann Hematol; 2006 Jun; 85(6):413-4. PubMed ID: 16525787
[No Abstract] [Full Text] [Related]
3. Factor V Leiden and prothrombin gene G20210A mutations are uncommon in portal vein thrombosis in India.
Sharma S; Kumar SI; Poddar U; Yachha SK; Aggarwal R
Indian J Gastroenterol; 2006; 25(5):236-9. PubMed ID: 17090840
[TBL] [Abstract][Full Text] [Related]
4. Portal and mesenteric vein thrombosis in a patient heterozygous for a mutation (Arg506-->Gln) in the factor V gen (factor V Leiden).
Piñar A; Saenz R; Rebollo J; Gomez-Parra M; Carrasco F; Herrerias JM; Jimenez-Saenz M
J Clin Gastroenterol; 1998 Dec; 27(4):361-3. PubMed ID: 9855272
[TBL] [Abstract][Full Text] [Related]
5. Factor V Leiden: is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?
Biswas A; Bajaj J; Ranjan R; Meena A; Akhter MS; Yadav BK; Sharma V; Saxena R
Clin Chim Acta; 2008 Jun; 392(1-2):21-4. PubMed ID: 18342013
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of the Factor V Leiden Mutation Arg534Gln in Western Region of Saudi Arabia: Functional Alteration and Association Study With Different Populations.
Athar M; Abduljaleel Z; Ghita IS; Albagenny AA; Halawani SH; Alkazmi MM; Elbjeirami WM; Alquthami K; Alkhuzae MM; Ragab FM; Al-Allaf FA
Clin Appl Thromb Hemost; 2021; 27():1076029620978532. PubMed ID: 33448877
[TBL] [Abstract][Full Text] [Related]
8. Portal, splenic and mesenteric vein thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
Grouzi E; Politou M; Douramani P; Merkouri E; Gialeraki A; Brountzos H; Perros G; Travlou A
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):722-5. PubMed ID: 19734780
[TBL] [Abstract][Full Text] [Related]
9. Frequent factor II G20210A mutation in idiopathic portal vein thrombosis.
Chamouard P; Pencreach E; Maloisel F; Grunebaum L; Ardizzone JF; Meyer A; Gaub MP; Goetz J; Baumann R; Uring-Lambert B; Levy S; Dufour P; Hauptmann G; Oudet P
Gastroenterology; 1999 Jan; 116(1):144-8. PubMed ID: 9869612
[TBL] [Abstract][Full Text] [Related]
10. Pseudohomozygosity for activated protein C resistance is a risk factor for venous thrombosis.
Castaman G; Tosetto A; Ruggeri M; Rodeghiero F
Br J Haematol; 1999 Jul; 106(1):232-6. PubMed ID: 10444192
[TBL] [Abstract][Full Text] [Related]
11. The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis.
Egesel T; Büyükasik Y; Dündar SV; Gürgey A; Kirazli S; Bayraktar Y
J Clin Gastroenterol; 2000 Jan; 30(1):66-71. PubMed ID: 10636214
[TBL] [Abstract][Full Text] [Related]
12. Mesenteric vein thrombosis in a pregnant patient heterozygous for the factor V (1691 G --> A) Leiden mutation.
Sönmezer M; Aytaç R; Demirel LC; Kurtay G
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):234-5. PubMed ID: 15140521
[TBL] [Abstract][Full Text] [Related]
13. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
[TBL] [Abstract][Full Text] [Related]
14. Prothrombin G20210A gene variant is not associated with idiopathic portal vein thrombosis in an area endemic for portal vein thrombosis.
Koshy A; Jeyakumari M
Ann Hematol; 2006 Feb; 85(2):126-8. PubMed ID: 16283309
[TBL] [Abstract][Full Text] [Related]
15. Small bowel infarction in a 10-year-old child with a factor V Leiden mutation.
Brown P; Hardin W; Hilliard L; Mroczek-Musulman E; Royal S
J Pediatr Gastroenterol Nutr; 1999 May; 28(5):506-9. PubMed ID: 10328127
[No Abstract] [Full Text] [Related]
16. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.
Rintelen C; Mannhalter C; Lechner K; Eichinger S; Kyrle PA; Papagiannopoulos M; Schneider B; Pabinger I
Blood Coagul Fibrinolysis; 1999 Mar; 10(2):101-5. PubMed ID: 10192659
[TBL] [Abstract][Full Text] [Related]
17. Mesenteric vein thrombosis due to factor V Leiden gene mutation.
Bergenfeldt M; Svensson PJ; Borgström A
Br J Surg; 1999 Aug; 86(8):1059-62. PubMed ID: 10460643
[TBL] [Abstract][Full Text] [Related]
18. Mesenteric vein thrombosis in a patient heterozygous for factor V Leiden and G20210A prothrombin genotypes.
Karmacharya P; Aryal MR; Donato A
World J Gastroenterol; 2013 Nov; 19(43):7813-5. PubMed ID: 24282370
[TBL] [Abstract][Full Text] [Related]
19. Mesenteric and portal vein thrombosis associated with hyperhomocysteinemia and heterozygosity for factor V Leiden mutation.
Famularo G; Minisola G; Nicotra GC; Simone CD
World J Gastroenterol; 2005 Dec; 11(48):7700-1. PubMed ID: 16437705
[No Abstract] [Full Text] [Related]
20. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R
Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
